Grant of Options

RNS Number : 7517Z

Synairgen plc

12 March 2013

Synairgen plc ('Synairgen' or the 'Company')

Grant of options

On 11 March 2013 the Board of Synairgen granted options ("Options") over 906,343 ordinary shares of one pence each in the capital of the Company ("Ordinary Shares") at an exercise price of one pence per Ordinary Share. The Options represent in aggregate 1.21 per cent. of the existing issued share capital.

The Options are issued under the Company's existing Long Term Incentive Plan and are exercisable between 11 March 2016 and 10 March 2023, subject to achievement of performance criteria related to the increase in the total shareholder return of the Company.

Historically, grants under the Company's Long Term Incentive Plan were made in September following the publication of the final results for the year to June. The last grants were made in September 2011. Following, the change in year-end to 31 December, it was not considered appropriate to accelerate the date of grants, so no grants were made during 2012.

The following Options were issued to directors of the Company on 11 March 2013:

Director	Options Issued
Richard Marsden	245,732
Dr. Phillip Monk	182,776
John Ward	223,393

Following the issue of the Options, the interests of the directors of the Company at 11 March 2013 are as follows:

Director	Total Options Issued	Ordinary Shares	Total Interest	% of issued share capital
Richard Marsden	2,587,764	110,972	2,698,736	3.59%
Dr. Phillip Monk	1,418,747	28,592	1,447,339	1.93%
John Ward	1,996,149	243,912	2,240,061	2.98%
Simon Shaw (Note 1)	-	1,408,879	1,408,879	1.87%
Iain Buchanan	212,765	112,741	325,506	0.39%
Dr. David Campbell	-	294,259	294,259	0.39%
Paul Clegg (Note 2)	250,000	204,244	454,244	0.60%
Prof. Stephen Holgate (Note 3)	-	858,360	858,360	1.14%